Segment and Geographic Information

6 Months Ended

Jun. 30, 2015

Segment Reporting [Abstract]

Segment and Geographic Information

Segment and Geographic Information

The Company manages its business and operations as one segment and is focused on advancing the treatment of acute and intensive care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. Revenues reported to date are derived primarily from the sales of Angiomax in the United States.

The geographic segment information provided below is classified based on the major geographic regions in which the Company operates.

	Three Months Ended June 30,								Six Months Ended June 30,
	2015				2014				2015			2014
	(in thousands)								(in thousands)
Net revenue:
United States	$	85,261	94.2	%	$	172,898	94.1	%	$	206,025	94.9%	$	340,377	94.3%
Europe	4,547		5.0	%	9,790		5.3	%	9,637		4.4%	18,509		5.1%
Rest of world	664		0.8	%	1,086		0.6	%	1,326		0.7%	2,123		0.6%
Total net revenue	$	90,472	100.0	%	$	183,774	100.0	%	$	216,988	100.0%	$	361,009	100.0%

	June 30, 2015				December 31, 2014
	(in thousands)
Long-lived assets:
United States	$	1,397,423	99.4	%	$	1,218,370	99.3	%
Europe	8,762		0.6	%	8,899		0.7	%
Rest of world	—		—	%	15		—	%
Total long-lived assets	$	1,406,185	100.0	%	$	1,227,284	100.0	%